# Martha A. Zeiger

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/martha-a-zeiger/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,567 |
| Field | Thyroid Cancer Diagnosis and Treatment |
| h-index | 62 |
| i10-index | 165 |
| Last Known Institution | National Institutes of Health |
| OpenAlex ID | https://openalex.org/A5025622172 |
| ORCID iD | https://orcid.org/0000-0001-8998-0858 |
| Works | 292 |

## Researcher papers

- [BRAF Mutation Predicts a Poorer Clinical Prognosis for Papillary Thyroid Cancer](https://scholariq.org/papers/braf-mutation-predicts-a-poorer-clinical-prognosis-for-papillary-thyroid-cancer/)
- [Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer](https://scholariq.org/papers/association-between-braf-v600e-mutation-and-mortality-in-patients-with-papillary/)
- [American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules](https://scholariq.org/papers/american-association-of-clinical-endocrinologists-and-associazione-medici/)

## Researcher topics

- [Thyroid Cancer Diagnosis and Treatment](https://scholariq.org/topics/thyroid-cancer-diagnosis-and-treatment-2/)
- [Thyroid and Parathyroid Surgery](https://scholariq.org/topics/thyroid-and-parathyroid-surgery-2/)
- [Thyroid Disorders and Treatments](https://scholariq.org/topics/thyroid-disorders-and-treatments-2/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)

## Researcher university

- [National Institutes of Health](https://scholariq.org/institutions/national-institutes-of-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.